+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adrenal insufficiency in early phase of pediatric acute lung injury/acute respiratory distress syndrome



Adrenal insufficiency in early phase of pediatric acute lung injury/acute respiratory distress syndrome



Journal of Critical Care 22(4): 314-318



Adequate adrenal function is essential to survive critical illness. Several recent articles have reported the significant effect of adrenal insufficiency (AI) in patients with sepsis. However, the prevalence of AI in pediatric acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is so far still scanty. Thus, we elected to study its prevalence and its clinical outcome. This is a cross-sectional observational study. We enrolled eligible infants and children aged between 1 month and 15 years who were admitted to our tertiary pediatric intensive care unit from February 1, 2005, to December 31, 2005, with ALI or ARDS diagnosed by the American-European Consensus criteria. A short corticotropin stimulation test (250 microg) was done within 24 hours of enrollment, and all clinical data were also recorded. Cortisol levels were measured at baseline, 30 minutes, and 60 minutes posttest. Adrenal insufficiency was defined as a baseline cortisol level of less than 15.1 microg/dL or an increment of cortisol level of less than 9 microg/dL after the adrenocorticotropic hormone stimulation test. Of 507 patients admitted to the pediatric intensive care unit, there were 20 diagnosed with ALI/ARDS. Of 20 children, 16 met the inclusion criteria and had none of the exclusion criteria. Of 16, there were 9 (56%) with ARDS, and 7 (44%) of 12 had ALI. The prevalence of AI was observed in 37.5% (6/16), diagnosed by baseline level criteria in 25% (4/16) and by incremental criteria in 12.5% (2/16). The Baseline level of the adrenocorticotropic hormone was 7.8 +/- 5 (nmol/L). The median age in the AI group was 2 months. Of 6 children, 5 (83.3%) were in the ARDS group. Pediatric Risk of Mortality III score was significantly higher in the AI group compared with that in the non-AI (P < .05). Initial Pao(2)/fraction of inspired oxygen ratio tended to be lower in the AI group (123.2 +/- 62.2) compared with that in the non-AI group (183.8 +/- 79.1), although not statistically significant (P = .1). The mortality was also not statistically different between the AI (1/6, 16.7%) and the non-AI groups (1/10, 10%). Our study demonstrated that the prevalence of AI was common in pediatric ALI/ARDS. These results would be an initial step to further study the impact of AI on clinical outcomes of these children in a larger scale.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051388437

Download citation: RISBibTeXText

PMID: 18086402

DOI: 10.1016/j.jcrc.2007.03.003


Related references

Acute lung injury/acute respiratory distress syndrome: progress in diagnosis and treatment topics: I. Pathogenesis and pathophysiology; 1. The concept and definitions of acute lung injury and acute respiratory distress syndrome. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 100(6): 1518-1521, 2011

Current approaches to the treatment of severe hypoxic respiratory insufficiency (acute lung injury; acute respiratory distress syndrome). Deutsche Medizinische Wochenschrift 136(5): 186-189, 2011

The outcomes of children with pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S118-S131, 2016

Monitoring of children with pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S86-101, 2016

Nonpulmonary treatments for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S73-S85, 2016

Noninvasive support and ventilation for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S102-S110, 2016

Extracorporeal support in children with pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S111-S117, 2016

Comorbidities and assessment of severity of pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S41-S50, 2016

Ventilatory support in children with pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S51-S60, 2016

Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S23-S40, 2016

Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatric Critical Care Medicine 16(5 Suppl 1): S61-S72, 2016

Acute lung injury and acute respiratory distress syndrome in the pediatric patient. Critical Care Nursing Clinics of North America 17(4): 311-8, Ix, 2005

Acute lung injury and acute respiratory distress syndrome: extracorporeal life support and liquid ventilation for severe acute respiratory distress syndrome in adults. Seminars in Respiratory and Critical Care Medicine 27(4): 416-425, 2006

Toward a more accurate definition of acute lung injury and the acute respiratory distress syndrome in pediatric patients. Pediatric Critical Care Medicine 7(4): 393-394, 2006

Surfactant Replacement Therapy in Pediatric Acute Lung Injury/Acute Respiratory Distress Syndrome. Current Respiratory Medicine Reviews 5(3): 160-167, 2009